azomycin has been researched along with Leukemia P388 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bardos, TJ; Dunn, JA; Earle, J; MacDiarmid, JE; Perlman, ME; Piscitelli, TA; Rose, WC; Wampler, GL | 1 |
1 other study(ies) available for azomycin and Leukemia P388
Article | Year |
---|---|
Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Line; Cell Survival; Indicators and Reagents; Leukemia P388; Mice; Mice, Inbred Strains; Molecular Structure; Nitroimidazoles; Organophosphorus Compounds; Radiation-Sensitizing Agents; Structure-Activity Relationship; Whole-Body Irradiation | 1991 |